Patents by Inventor Matthew T. Reding

Matthew T. Reding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of HCV NS5B polymerase
    Patent number: 6930106
    Abstract: The present invention provides compounds of Formula I, compositions and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: August 16, 2005
    Assignee: Pharmacia & UpJohn Company
    Inventors: Barry Craig Finzel, Lee A. Funk, Robert Charles Kelly, Matthew T. Reding, Nancy Anne Wicnienski
  • Inhibitors of HCV NS5B polymerase
    Publication number: 20040142993
    Abstract: The present invention provides compounds of Formula I, compositions and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.
    Type: Application
    Filed: June 30, 2003
    Publication date: July 22, 2004
    Inventors: Carlo Battistini, Francesco A. Casuscelli, Robert Charles Kelly, Linda L. Maggiora, Mark Allen Mitchell, Claudia Piutti, Matthew T. Reding
  • Inhibitors of HCV NS5B polymerase
    Publication number: 20040142989
    Abstract: The present invention provides compounds of Formula I, compositions and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.
    Type: Application
    Filed: June 30, 2003
    Publication date: July 22, 2004
    Inventors: Barry Craig Finzel, Lee A. Funk, Robert Charles Kelly, Matthew T. Reding, Nancy Anne Wicnienski